FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377539005: Product containing precisely methyclothiazide 2.5 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3699951019 Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet en Synonym Active Case insensitive SNOMED CT core
3699952014 Product containing precisely methyclothiazide 2.5 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a Methyclothiazide and reserpine only product in oral dose form true Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Plays role Diuretic therapeutic role true Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a Reserpine-containing product false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a Methyclothiazide-containing product false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Reserpine - chemical false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Methyclothiazide false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a Methyclothiazide- and reserpine-containing product false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Reserpine false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Centrally acting antihypertensive agent false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has manufactured dose form Tablet false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a Product manufactured as oral dose form false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has BoSS Methyclothiazide true Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value 2.5 false Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has BoSS Reserpine true Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit mg false Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Reserpine false Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has BoSS Reserpine false Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value 0.1 false Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Methyclothiazide false Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has BoSS Methyclothiazide false Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value 2.5 false Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Methyclothiazide false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has active ingredient Reserpine false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has unit of presentation Tablet true Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Is a Rauwolfia alkaloid-containing product in oral dose form false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has precise active ingredient Methyclothiazide true Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has precise active ingredient Reserpine true Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Count of base of active ingredient 2 false Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator value 100 false Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength numerator unit mcg true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start